1. Japan's Takeda Pharmaceutical (TKPYY) agreed to buy Zurich-based Nycomed for $9.1 billion, in part to cushion the blow of losing patent protection on Actos, its best-selling diabetes pill.
2. The U.S. Treasury Dept. and American International Group (AIG) raised $8.7 billion in a sale of AIG shares, bringing the insurer one step closer to independence after its 2008 bailout.
3. Thermo Fisher Scientific (TMO), the No. 1 maker of lab instruments, is buying Sweden's Phadia for $3.5 billion to expand in testing for allergies and autoimmune diseases.
4. Hungary's government is paying $2.7 billion to Russian oil producer Surgutneftegas for its 21.2 percent stake in Hungary's largest oil refiner, Mol, to thwart a takeover by Surgutneftegas.
5. Toshiba (TOSBF) will pay $2.3 billion for Swiss electronic metering company Landis & Gyr to bolster its smart power-grid operations.
6. Malaysian billionaire Robert Kuok offered to buy all the shares in Allgreen Properties through his firm Brookvale Investments, valuing the developer at $2 billion.
7. Moscow-based Yandex (YNDX), the owner of Russia's most popular search engine, raised $1.3 billion in a U.S. IPO that values the company at about $8 billion.
8. Labelux, the privately held luxury group that owns Bally, agreed to buy shoe company Jimmy Choo from TowerBrook Capital Partners for $811 million.
9. Canada's Valeant Pharmaceuticals (VRX) International, maker of CeraVe cleansers and creams, is buying Lithuania-based Sanitas for about $442 million to add dermatology drugs and expand into Eastern and Central European markets.
10. Elizabeth Taylor's estate is asking $8.6 million for the five-bedroom Bel-Air home where the star lived until her death in March.